2′-O-Methyladenosine CAS#: 2140-79-6; ChemWhat Code: 96875

IdentificationPhysical DataSpectra
Route of Synthesis (ROS)Safety and HazardsOther Data

Identification

Product Name2′-O-Methyladenosine
IUPAC Name(2R,3R,4R,5R)-5-(6-aminopurin-9-yl)-2-(hydroxymethyl)-4-methoxyoxolan-3-ol
Molecular Structure2-O-Methyladenosine-CAS-2140-79-6
CAS Registry Number 2140-79-6
MDL NumberMFCD00056002
Synonyms2′-O-Methyladenosine
2140-79-6
Adenosine, 2′-O-methyl-
(2R,3R,4R,5R)-5-(6-amino-9H-purin-9-yl)-2-(hydroxymethyl)-4-methoxytetrahydrofuran-3-ol
2′-O-Methyl adenosine
(2R,3R,4R,5R)-5-(6-aminopurin-9-yl)-2-(hydroxymethyl)-4-methoxyoxolan-3-ol
CHEMBL73237
2′-O-METHYL-ADENOSINE
02YX82IHZ5
CHEBI:69426
cordysinin B
MFCD00056002
C11H15N5O4
UNII-02YX82IHZ5
SCHEMBL25936
2′-O-Me-A
DTXSID50175671
BCP17411
BDBM50144945
HG1274
PDSP1_001054
PDSP2_001038
AKOS016003815
AC-8216
CS-W012268
HY-W011552
(2R,3R,4R,5R)-5-(6-aminopurin-9-yl)-2-(hydroxymethyl)-4-methoxy-tetrahydrofuran-3-ol
BP-58835
DS-14586
PD018166
Q63392855
5-(6-amino-9H-purin-9-yl)-2-(hydroxymethyl)-4-methoxyoxolan-3-ol
Molecular FormulaC11H15N5O4
Molecular Weight281.27
InChIInChI=1S/C11H15N5O4/c1-19-8-7(18)5(2-17)20-11(8)16-4-15-6-9(12)13-3-14-10(6)16/h3-5,7-8,11,17-18H,2H2,1H3,(H2,12,13,14)/t5-,7-,8-,11-/m1/s1 
InChI KeyFPUGCISOLXNPPC-IOSLPCCCSA-N
Isomeric SMILESCO[C@@H]1[C@@H]([C@H](O[C@H]1N2C=NC3=C(N=CN=C32)N)CO)O

Physical Data

AppearanceWhite powder
Melting Point, °C Solvent (Melting Point)
204 – 206
202 – 203ethanol
200 – 201
198 – 201
203 – 207
Density, g·cm-3
1.482

Spectra

Description (NMR Spectroscopy)Nucleus (NMR Spectroscopy)Solvents (NMR Spectroscopy)Temperature (NMR Spectroscopy), °C Frequency (NMR Spectroscopy), MHz
Chemical shifts, Spectrum1H25
Chemical shifts1Hdimethylsulfoxide-d625500
Chemical shifts13Cdimethylsulfoxide-d6125
Chemical shifts1HCD3OD500
Description (IR Spectroscopy)Solvent (IR Spectroscopy)Comment (IR Spectroscopy)
Bands neat (no solvent, solid phase)
Bandspotassium bromide
Description (UV/VIS Spectroscopy)Solvent (UV/VIS Spectroscopy)Comment (UV/VIS Spectroscopy)Absorption Maxima (UV/VIS), nmExt./Abs. Coefficient, l·mol-1cm-1
Absorption maximaH2O25914000
Absorption maxima259400
Absorption maximaH2ORemark: pH 725913804

Route of Synthesis (ROS)

Route of Synthesis (ROS) of 2'-O-Methyladenosine CAS 2140-79-6
Route of Synthesis (ROS) of 2′-O-Methyladenosine CAS 2140-79-6
ConditionsYield
With 1H-imidazole In pyridine at 65℃; for 12h; silylation;93%
With 1H-imidazole; dmap In N,N-dimethyl-formamide at 20℃; for 28h;83%
With pyridine; 1H-imidazole at 20℃; for 15h;

Experimental Procedure
117-130 Preparation of compound 7-2:
To a solution of 7-1 (15.0 g, 53.3 mmol) in dry pyridine (150 mL) was added TBSC1 (20.0 g, 133.3 mmol) and Imidazole (10.8 g, 159.9 mmol). The mixture was stirred at r.t. for l5h. TLC showed 7-1 was consumed completely. The reaction mixture was concentrated in vacuo to give residue. The residue was quenched with DCM (500 mL). The DCM layer was washed with H2O (1 L*2) 2 times and brine. The DCM layer concentrated in vacuo to give crude 7-2 (27.2 g, 53.3 mmol) as a yellow oil. The crude 7-2 was used in next step directly. ESI-LCMS m/z 510.5 [M+H]+.
99%

Safety and Hazards

No data available


Other Data

No data available

Druglikeness
Lipinski rules component
Molecular Weight281.271
logP-1.327
HBA9
HBD3
Matching Lipinski Rules4
Veber rules component
Polar Surface Area (PSA)128.54
Rotatable Bond (RotB)3
Matching Veber Rules2
Quantitative Results
1 of 25Comment (Pharmacological Data)Bioactivities present
ReferenceNovel adenosine derivatives and pharmaceutical composition containing them as an active ingredient
2 of 25Comment (Pharmacological Data)Bioactivities present
ReferenceMethylation of Adenosine and Related Nucleosides with Trimethylselenonium Hydroxyde, and Regiospecific Effects of Copper(II) Ions
3 of 25Comment (Pharmacological Data)Bioactivities present
ReferenceNucleic acid related compounds. 36. Synthesis of the 2′-O-methyl and 3′-O-methyl ethers of guanosine and 2-aminoguanosine and correlation of O’-methylnucleoside 13C nmr spectral shifts
4 of 25Comment (Pharmacological Data)Bioactivities present
ReferenceThe first synthesis of herbicidin B. stereoselective construction of the tricyclic undecose moiety by a conformational restriction strategy using steric repulsion between adjacent bulky silyl protecting groups on a pyranose ring
5 of 25Comment (Pharmacological Data)Bioactivities present
ReferenceInhibitory actvity of the compound against Fatty acid amide hydrolase in 0.1 M sodium phosphate, pH 8.0
6 of 25Comment (Pharmacological Data)Bioactivities present
ReferenceRecognition and detection of 8-oxo-rG in RNA using the DNA/OMeRNA chimera probes containing fluorescent adenosine-diazaphenoxazine analog
7 of 25Comment (Pharmacological Data)Bioactivities present
ReferenceNucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase
8 of 25Comment (Pharmacological Data)Bioactivities present
ReferenceRNAi agents and compositions for inhibiting expression of apolipoprotein C-III (APOC3)
9 of 25Comment (Pharmacological Data)Bioactivities present
ReferenceMODIFIED SHORT INTERFERING NUCLEIC ACID (SINA) MOLECULES AND USES THEREOF
10 of 25Comment (Pharmacological Data)Bioactivities present
ReferenceAdolescent alcohol exposure changes RNA modifications in adult brain by mass spectrometry-based comprehensive profiling analysis
Use Pattern
2′-O-Methyladenosine CAS#: 2140-79-6 (N-EPSILON-L-LYSINE METHYL ESTER HYDROCHLORIDE SALT and it is used in IVD.

Buy Reagent

No reagent supplier? Send quick inquiry to ChemWhat
Want to be listed here as a reagent supplier? (Paid service) Click here to contact ChemWhat

Approved Manufacturers

Want to be listed as an approved manufacturer (Requires approvement)? Please download and fill out this form and send back to approved-manufacturers@chemwhat.com

Contact Us for Other Help

Contact us for other information or services Click here to contact ChemWhat